Stockreport

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

DSS, Inc.  (DSS) 
NASDAQ:AMEX Investor Relations: dsssecure.com
PDF ROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company focused on innovation-driven business models, today announce [Read more]